U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Serotonin Antagonists [Pharmacological Action]

Tree Number(s): D012702

MeSH Unique ID: D012702

  • EEDQ (Supplementary Concept)
  • pipamperone (Supplementary Concept)
  • xylamidine (Supplementary Concept)
  • tolfenamic acid (Supplementary Concept)
  • iprazochrome (Supplementary Concept)
  • clovoxamine (Supplementary Concept)
  • cianopramine (Supplementary Concept)
  • 6-nitroquipazine (Supplementary Concept)
  • mesulergine (Supplementary Concept)
  • LY 53857 (Supplementary Concept)
  • bemesetron (Supplementary Concept)
  • setoperone (Supplementary Concept)
  • cyanopindolol (Supplementary Concept)
  • amperozide (Supplementary Concept)
  • butanserin (Supplementary Concept)
  • renzapride (Supplementary Concept)
  • 2-((2-(dimethylamino)ethyl)thio)-3-phenylquinoline (Supplementary Concept)
  • zacopride (Supplementary Concept)
  • McN 5652 (Supplementary Concept)
  • 1-(2-methoxyphenyl)-4-(4-(2-phthalimido)butyl)piperazine (Supplementary Concept)
  • deramciclane (Supplementary Concept)
  • binospirone mesylate (Supplementary Concept)
  • UH 301 (Supplementary Concept)
  • sarpogrelate (Supplementary Concept)
  • zatosetron (Supplementary Concept)
  • fananserin (Supplementary Concept)
  • azasetron (Supplementary Concept)
  • ramosetron (Supplementary Concept)
  • altanserin (Supplementary Concept)
  • 2-methoxy-4-amino-5-chlorobenzoic acid 2-(diethylamino)ethyl ester (Supplementary Concept)
  • SR 46349B (Supplementary Concept)
  • DuP 734 (Supplementary Concept)
  • volinanserin (Supplementary Concept)
  • WAY 100135 (Supplementary Concept)
  • GR 113808 (Supplementary Concept)
  • dotarizine (Supplementary Concept)
  • SB 204070A (Supplementary Concept)
  • 4-(2'-methoxyphenyl)-1-(2'-(N-(2''-pyridinyl)-4-iodobenzamido)ethyl)piperazine (Supplementary Concept)
  • N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridinyl)cyclohexanecarboxamide (Supplementary Concept)
  • GR 127935 (Supplementary Concept)
  • alosetron (Supplementary Concept)
  • ziprasidone (Supplementary Concept)
  • SB 206553 (Supplementary Concept)
  • 3-(3-(dimethylamino)propyl)-4-hydroxy-N-(4-(4-pyridinyl)phenyl)benzamide (Supplementary Concept)
  • 8-(5-(5-amino-2,4-dimethoxyphenyl)-5-oxopentyl)-1,3,8-triazaspiro(4.5)decane-2,4-dione (Supplementary Concept)
  • 3,N-dimethyl-N-(1-methyl-3-(4-methylpiperidin-1-yl)propyl)benzenesulfonamide (Supplementary Concept)
  • 2a-(4-phenyl-1,2,3,6-tetrahydropyridyl)cyclohex(a-3,4)indole-2-one (Supplementary Concept)
  • 2-(3,5-dimethylpiperidino)ethyl 4-amino-5-chloro-2-methoxybenzoate (Supplementary Concept)
  • 2-amino-4-(4-fluoronaphth-1-yl)-6-isopropylpyrimidine (Supplementary Concept)
  • 1-(2-methoxyphenyl)-4-(4--(2-phthalimido)cyclohexyl)piperazine (Supplementary Concept)
  • 4-(3-(1-benzotriazolyl)cyclohexyl)-1-(2-methoxyphenyl)piperazine (Supplementary Concept)
  • N-(1-azabicyclo(2.2.2)oct-3-yl)benzimidazole-4-carboxamide (Supplementary Concept)
  • N-(1-azabicyclo(2.2.2)oct-3-yl)--6-chlorobenzimidazole-4-carboxamide (Supplementary Concept)
  • N-(1-azabicyclo(2.2.2)oct-3-yl)-6--chloro-7-nitrobenzimidazole-4-carboxamide (Supplementary Concept)
  • 2-ethyl-5-methoxy-N,N-dimethyltryptamine (Supplementary Concept)
  • LY 426965 (Supplementary Concept)
  • SL 88.0338 (Supplementary Concept)
  • LY 367265 (Supplementary Concept)
  • REC 15-3079 (Supplementary Concept)
  • 4-((1-(2-(2,4-difluorophenyl)ethyl)-4-piperidinyl)sulfonyl)benzonitrile (Supplementary Concept)
  • 4-((1-(2-(2,4-difluorophenyl)ethyl)-4-piperidinyl)sulfonyl)benzamide (Supplementary Concept)
  • 1-(4-fluorophenyl)-2-(4-(phenylsulfonyl)-1-piperidinyl)ethanone (Supplementary Concept)
  • LY 393558 (Supplementary Concept)
  • 5-((N-propylpiperidin-4-yl)methoxy)-1,2,3,4-tetrahydrobenzo(h)(1,6)naphthyridine (Supplementary Concept)
  • N-(5-methyl-8-(4-methylpiperazin-1-yl)-1,2,3,4-tetrahydro-2-naphthyl)-4-morpholinobenzamide (Supplementary Concept)
  • 2-(4-((6-amino-1,3-dioxo-1H-benzo(de)isoquinolin-2(3H)-yl)methyl)piperidin-1-yl)ethyl 4-amino-5-chloro-2-methoxybenzoate (Supplementary Concept)
  • 3-(benzenesulfonyl)-2-(methylsulfanyl)pyrido(1,2-a)pyrimidin-4-ylidenamine (Supplementary Concept)
  • (2-(6-fluoro-1H-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine (Supplementary Concept)
  • 1-((2-bromophenyl)sulfonyl)-5-methoxy-3-((4-methyl-1-piperazinyl)methyl)-1H-indole dimesylate monohydrate (Supplementary Concept)
  • AVN-492 (Supplementary Concept)
  • 5-(4-fluorophenyl)-3-(2-hydroxy-3-(4-(2-methoxyphenyl)piperazin-1-yl)propyl)-5-methylhydantoin (Supplementary Concept)
  • Bufotenin (MeSH Term)
  • Cinanserin (MeSH Term)
  • Clozapine (MeSH Term)
  • Cyproheptadine (MeSH Term)
  • N,N-Dimethyltryptamine (MeSH Term)
  • Ketanserin (MeSH Term)
  • Lysergic Acid Diethylamide (MeSH Term)
  • Metergoline (MeSH Term)
  • Methiothepin (MeSH Term)
  • Methysergide (MeSH Term)
  • Mianserin (MeSH Term)
  • Nafronyl (MeSH Term)
  • Fenclonine (MeSH Term)
  • Pindolol (MeSH Term)
  • Pizotyline (MeSH Term)
  • Ritanserin (MeSH Term)
  • Risperidone (MeSH Term)
  • BRL 15572 (Supplementary Concept)
  • MM 77 (Supplementary Concept)
  • N-(8'-hydroxy-2'-methyl-5'-(2-methylpropyl)-3',6'-dioxo-7'-(phenylmethyl)oxazolidino(2,3-c)piperazin-2'-yl) 6-methylergoline-8-carboxamide (Supplementary Concept)
  • 5-fluoro-8-(4-(4-(6-methoxyquinolin-8-yl)piperazin-1-yl)piperidin-1-yl)quinoline (Supplementary Concept)
  • isamoltane (Supplementary Concept)
  • 3-(cyclobutyl(3-(5-fluoro-1H-indol-3-yl)propyl)amino)-8-fluorochromane-5-carboxamide (Supplementary Concept)
  • N-(2-methyl-(4-indolyl-1-piperazinyl)ethyl)-N-(2-pyridinyl)cyclohexane carboxamide (Supplementary Concept)
  • 1-(4-(2-methoxyisopropyl)phenyl)-3-(2-(4-methylpiperazin-1-yl)benzyl)pyrrolidin-2-one (Supplementary Concept)
  • nefazodone (Supplementary Concept)
  • 7-methyl-2,3-dimethoxy-5,6,7,8,9,14-hexahydrodibenz(d,g)azecine (Supplementary Concept)
  • pimavanserin (Supplementary Concept)
  • AR 246686 (Supplementary Concept)
  • 9-(4-methylpiperazin-1-yl)pyrrolo(2,1-b)benzothiazepine (Supplementary Concept)
  • YKP 1358 (Supplementary Concept)
  • APD791 (Supplementary Concept)
  • 5-(((4-benzo(a)isothiazol-3-yl)piperazin-1-yl)methyl)-6-chloroindolin-2-one (Supplementary Concept)
  • 2-(4-methoxyphenyl)-N-(4-methylbenzyl)-N-(1-methylpiperidin-4-yl)acetamide (Supplementary Concept)
  • itasetron (Supplementary Concept)
  • dolasetron (Supplementary Concept)
  • 3-(4-methoxybenzyl)-N-(3-(2-piperidin-1-yl)ethyl)-2,4-dioxoquinazoline-7-carboxamide (Supplementary Concept)
  • 2-(4-allylpiperazin-1-yl)-1,8-naphthyridine-3-carbonitrile (Supplementary Concept)
  • hexahydro-1H-pyrrolizin-1-ylmethyl 1-methyl-1H-indole-3-carboxylate (Supplementary Concept)
  • Aripiprazole (MeSH Term)
  • Paliperidone Palmitate (MeSH Term)
  • Lurasidone Hydrochloride (MeSH Term)
  • Mirtazapine (MeSH Term)
  • Ondansetron (MeSH Term)
  • Granisetron (MeSH Term)
  • Palonosetron (MeSH Term)
  • Vortioxetine (MeSH Term)
  • Tropisetron (MeSH Term)

Supplemental Content

Loading ...